Beam Therapeutics
Yahoo Finance • 14 hours ago
Peek Under The Hood: VB Has 14% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story
Yahoo Finance • 14 days ago
Interesting BEAM Put And Call Options For January 2028
Investors in Beam Therapeutics Inc (Symbol: BEAM) saw new options begin trading today, for the January 2028 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 858... Full story
Yahoo Finance • last month
Cathie Wood's ARK ETF bolsters biotech, trims defense stock
Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story
Yahoo Finance • 2 months ago
Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid promising tech
Prime Medicine, Inc. (NASDAQ:PRME) is a biotechnology company at the forefront of gene editing technology, focusing on developing treatments for serious genetic diseases. With a market capitalization of $499.5 million and a beta of 2.41, t... Full story
Yahoo Finance • 2 months ago
Clear Street reiterates Buy rating on Beam Therapeutics stock at $34
Investing.com - Clear Street has reiterated its Buy rating and $34.00 price target on Beam Therapeutics Inc (NASDAQ:BEAM), currently trading at $18.68, following the company’s second-quarter 2025 financial results and update on its BEAM-... Full story
Yahoo Finance • 2 months ago
PBF Energy declares $0.275 dividend
* PBF Energy (NYSE:PBF [https://seekingalpha.com/symbol/PBF]) declares $0.275/share quarterly dividend [https://seekingalpha.com/pr/20184218-pbf-energy-announces-second-quarter-2025-results-and-declares-dividend-of-0_275-per-share], in l... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK buys Tempus AI stock, sells Block and Roku
Cathie Wood’s ARK ETFs disclosed their daily trades for Wednesday, July 9th, 2025, with a significant focus on the tech and healthcare sectors. In the largest transaction of the day, ARK increased its position in Tempus AI Inc (NYSE:TEM),... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK buys CRSP stock, sells ROKU and MASS
In the ever-evolving landscape of exchange-traded funds, Cathie Wood’s ARK ETFs remain a focal point for investors seeking exposure to disruptive innovation. The daily trade report for Tuesday, 08 July 2025, showcases ARK’s latest strategi... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETF bolsters Beam stock, sheds Roblox
Cathie Wood’s ARK ETF published their daily trades for Monday, July 7th, 2025, revealing a continued interest in genomics with a significant investment in Beam Therapeutics Inc (NASDAQ:BEAM), while reducing positions in several other com... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK adjusts with Beam, Compass, and Komatsu trades
Cathie Wood’s ARK ETFs disclosed their daily trades for Thursday, 3rd July 2025, with a mix of buys and sells across various sectors. The most significant trade of the day involved the sale of KOMATSU LTD (TYO:6301) shares, with ARKX (NYSE... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETFs buy Aerovironment, trim Roblox stock
Cathie Wood’s ARK ETFs have reported their daily trades for Wednesday, July 2nd, 2025, showcasing a mix of aggressive buys and strategic sells that may signal the firm’s shifting investment focus. The largest transaction of the day involve... Full story
Yahoo Finance • 3 months ago
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
Key Points The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Small-cap and... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETF adjusts holdings, sells Coinbase, buys Tesla
Cathie Wood’s ARK ETFs have made a series of trades on Friday, June 27, 2025, with a significant sell-off in Coinbase Global Inc (NASDAQ:COIN) and notable purchases including Tesla Inc (NASDAQ:TSLA) and SoFi Technologies Inc (NASDAQ:SOFI... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETFs shuffle healthcare and tech stock holdings
Cathie Wood’s ARK ETFs have made their daily trades for Wednesday, June 25th, 2025, with a significant focus on healthcare and technology stocks. The trades included both substantial acquisitions and divestitures, reflecting ARK’s ongoing... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETF trades Shopify, Toast stock amid tech focus
Cathie Wood’s ARK ETFs have revealed their daily trades for Tuesday, June 24th, 2025, with notable activity in the technology sector. ARK’s most significant trades of the day included purchases of Shopify Inc (NYSE:NASDAQ:SHOP) and Toas... Full story
Yahoo Finance • 3 months ago
Lilly-Verve deal sends gene editing stocks higher
[Illustration of DNA strand with molecular scissors] Love Employee/iStock via Getty Images Biotech firms focused on gene therapies traded higher after Eli Lilly (NYSE:LLY [https://seekingalpha.com/symbol/LLY]) agreed to acquire Boston-bas... Full story
Yahoo Finance • 3 months ago
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing company for up to $1.3 billion. Continue Reading View Comments... Full story
Yahoo Finance • 3 months ago
BEAM Therapeutics' SWOT analysis: base editing pioneer's stock faces pivotal year
BEAM Therapeutics, a biotechnology company focused on developing precision genetic medicines through base editing, stands at a critical juncture in its journey to bring innovative therapies to market. With a market capitalization of $1.62... Full story
Yahoo Finance • 4 months ago
Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 Congress
Updated Data from 17 Patients Consistent with Previously Presented Data; AllPatientsTreated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Patients Required a Me... Full story
Yahoo Finance • 4 months ago
Cathie Wood Picks Up GitLab Shares, Dumps Palantir and CoreWeave
June 12 - Cathie Wood's ARK ETFs added shares of GitLab (NASDAQ:GTLB) while trimming positions in Roblox (RBLX), Palantir Technologies (NASDAQ:PLTR) and CoreWeave (NASDAQ:CRWV). On Wednesday, ARK Innovation ETF (ARKK) and ARK Next Generat... Full story
